Search results
Results From The WOW.Com Content Network
The CPhA is a nonprofit organization that advocates for pharmacists in Canada. An external Editorial Advisory Committee of Canadian physicians and pharmacists advises CPhA about the strategic direction of their publications including CPS. CPS is also available online by subscription at www.pharmacists.ca. Most of the drug monographs in CPS are ...
Around 25% of India's drugs are fake, counterfeit or substandard. If the fake drugs market grows at the current rate of 25%, it will cross US$10 billion mark by 2017. Trade in fake drugs is driven caused by lack of adequate regulations, shortage of drug inspectors and a lack of lab facilities to check the purity of drugs.
However, surging demand for Lilly and Danish rival Novo Nordisk's weight-loss drugs, which can cost more than $1,000 for a month's supply, has prompted numerous sellers to offer compounded ...
Even though more doctors are open to prescribing the compounded weight loss drugs, Novo Nordisk and Eli Lilly staunchly oppose the practice. Both have filed multiple lawsuits against compounding ...
More than 4,200 doctors have faced criminal drug-related charges since 2014, around the time when illegally manufactured fentanyl entered the scene in the U.S., fueling tens of thousands of opioid ...
Canada Drugs. Canada Drugs otherwise known as CanadaDrugs.com, was an online pharmacy based in Winnipeg, Manitoba. It was started in 2001 by former Manitoba pharmacist Kristjan Thorkelson as an offshoot of a chain of four local pharmacies, called The Prescription Shop, in Winnipeg. With the company being one of the first in the suddenly-growing ...
The Controlled Drugs and Substances Act (French: Loi réglementant certaines drogues et autres substances) is Canada's federal drug control statute. Passed in 1996 under Prime Minister Jean Chrétien's government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drugs Act, and establishes eight Schedules of controlled substances and two Classes of precursors.
And the annual list price of Merck’s cancer drug Keytruda is $191,000 in the US, while in the UK, it’s $115,000; in Canada, it’s $112,000; in France, it’s $91,000; in Germany, it’s ...